Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Hemostemix Inc
HMTXF | US
0.04
USD0
0%
HMTXF | US
Loading StockChartView...
About Hemostemix Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
02/06/2026
Close
0.04
Open
0.04
High
0.04
Low
0.04
View Less
HMTXF | US
Risk
40.1
Sharpe
-0.40
Luna's Score
49/100
Recommendation
Hold
Luna says (HMTXF | US)
What's Working
Positive Momentum
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
0.0%1 month
40.1%3 months
133.7%6 months
127.7%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
39.23
Debt to equity
-0.55
Debt to assets
18.94
Ent. to EBITDA
-1.63
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-1.53M
MarketCap
3.31M
MarketCap(USD)
3.31M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.00
Range1M
0.01
Range3M
0.02
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.14
Price X volume
76.00
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.63 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 39.23 | 15.55 | Expensive |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 133.70 | 72.80 | Riskier |
| Debt to Equity | -0.55 | -1.23 | Expensive |
| Debt to Assets | 18.94 | 0.25 | Expensive |
| Market Cap | 3.31M | 3.66B | Emerging |
